<p>The present invention relates to a stable oral pharmaceutical composition comprising atorvastatin or its pharmaceutically acceptable salt and alkaline aluminium salts in an amount sufficient to prevent degradation of the atorvastatin or its pharmaceutically acceptable salt.</p>